CVECVE
US • —
$24.81
P/E
9.82
PEG
0.15
FCF Yield
—
Rev Growth YoY
-10.0% YoY
Gross Margin
37.5%
Health Score
6/10
D/E Ratio
0.45
Confidence
LOW
Business Snapshot
The company involved in this analysis operates in a sector with limited segment detail, making precise revenue generation mechanics unclear from the available data. Its market cap tier and specific competitive position within the industry cannot be determined due to incomplete financial scale metrics and a lack of segment or market share information. The company has posted earnings growth of 65.8% despite a revenue decline, suggesting a focus on profitability over expansion. The low Debt/Equity ratio of 0.45x points to a conservative capital structure, which is notable for financial stability.
Financial Health
The gross margin stands at 37.5%, though a year-over-year comparison is not available to assess direction, while the net margin is 9.5%, providing a moderate level of profitability relative to revenue. The balance sheet is characterised as conservative, with a Debt/Equity ratio of 0.45x indicating low leverage, and a current ratio of 1.57x suggesting adequate short-term liquidity to cover obligations...
Risk Assessment
- REVENUE DECELERATION — Revenue declined 10.0% year-over-year, signalling top-line contraction in the most recent reporting period compared to growth or stability in prior comparable periods.
- EARNINGS QUALITY — While 4 out of 4 recent quarters beat estimates, the 65.8% earnings growth occurred alongside a -10.0% revenue decline, raising questions about the sustainability of profit gains.
- DATA COMPLETENESS — Free cash flow data is unavailable, preventing a full assessment of cash generation versus reported net income and financial health.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed....
The gross margin stands at 37.5%, though a year-over-year comparison is not available to assess direction, while the net margin is 9.5%, providing a moderate level of profitability relative to revenue. The balance sheet is characterised as conservative, with a Debt/Equity ratio of 0.45x indicating low leverage, and a current ratio of 1.57x suggesting adequate short-term liquidity to cover obligations. Free cash flow data is unavailable, limiting the ability to assess the company's cash generation versus earnings quality. Overall financial health is moderate, supported by low debt and a reasonable net margin, though the absence of cash flow data makes it difficult to evaluate the company's ability to self-fund operations or future investments without relying on external financing.
- REVENUE DECELERATION — Revenue declined 10.0% year-over-year, signalling top-line contraction in the most recent reporting period compared to growth or stability in prior comparable periods. - EARNINGS QUALITY — While 4 out of 4 recent quarters beat estimates, the 65.8% earnings growth occurred alongside a -10.0% revenue decline, raising questions about the sustainability of profit gains. - DATA COMPLETENESS — Free cash flow data is unavailable, preventing a full assessment of cash generation versus reported net income and financial health. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives